Desmopressin
Also known as: DDAVP · Minirin
A synthetic vasopressin analog with enhanced antidiuretic potency and no vasoconstrictive effects. Clinical standard for diabetes insipidus and hemophilia A.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
~3 hours
0.1–0.4 mg oral or 10–40 mcg intranasal
Oral, intranasal, or IV
Mechanism of Action
Selectively activates V2 vasopressin receptors in renal collecting ducts to increase water reabsorption and release von Willebrand factor stores.
Key Research Areas
Frequently Asked Questions
What is Desmopressin?▾
How does Desmopressin work?▾
What is the recommended dosage for Desmopressin?▾
What is the half-life of Desmopressin?▾
Is Desmopressin FDA approved?▾
Research Disclaimer
The information provided about Desmopressin is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.